On June 11, 2024, ACTO, the only AI-powered Intelligent Field Excellence (IFE) platform built specifically for the life sciences industry, announced its acquisition of 4th Down Solutions (4DS), a pioneer in mobile and data-driven learning for biopharma companies. Founded in 2010, 4DS is known for transforming commercial training into a continuous, insight-driven process aimed at enhancing field sales performance.

The deal builds on a longstanding collaboration between ACTO, 4DS, and Encompass Communications and Learning, which has supported companies like Teva Pharmaceuticals in delivering more effective and engaging sales training. The acquisition will integrate 4DS’s continuous learning capabilities into ACTO’s AI-enabled IFE platform, further supporting pharmaceutical sales teams with real-time insights and adaptive learning strategies.

ACTO CEO Parth Khanna noted the strategic alignment between the two companies, highlighting 4DS’s trailblazing role in redefining training standards in the industry. Brett Howell, CEO of 4DS, emphasized the value this integration brings to clients and employees through expanded AI-driven solutions.

While the transaction value was not disclosed, legal counsel for ACTO was provided by Todd Bissett and Fabiola Alvarez of Gowling WLG.

This acquisition positions ACTO to lead the evolution of field force effectiveness in life sciences through innovative applications of AI and data insights.